<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02472951</url>
  </required_header>
  <id_info>
    <org_study_id>46559</org_study_id>
    <nct_id>NCT02472951</nct_id>
  </id_info>
  <brief_title>Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study</brief_title>
  <acronym>CutDM</acronym>
  <official_title>Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Scientific evidence for the dietary treatment of type 2 diabetes is insufficient. The
      investigators hypothesize that a lower carbohydrate content in the diabetic diet than the
      recommended 55 E% will decrease the postprandial glucose excursion, decrease insulinotropic
      factors like incretin hormones and decrease their insulinotropic effects due to their glucose
      dependency. This will reduce postprandial insulin concentration, resulting in an improved
      insulin sensitivity and glucose metabolism. This clinical study will examine in diabetic,
      prediabetic and healthy subjects the acute effects of short term highly controlled dietary
      low carbohydrate intervention on metabolic pathways with respect to insulin action,
      pancreatic islet function, lipid metabolism, incretin hormones, low grade inflammation in
      plasma and novel measures of fatty acid metabolism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>Measured during meal tests (2 days with each intervention)</time_frame>
    <description>Insulin sensitivity as measured by the oral minimal model applied to the meal test</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Type 2 diabetic subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Prediabetic subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low carbohydrate meals</intervention_name>
    <description>Meal macronutritional energy composition:
Carbohydrate 30% Protein 30% Fat 40%</description>
    <arm_group_label>Type 2 diabetic subjects</arm_group_label>
    <arm_group_label>Prediabetic subjects</arm_group_label>
    <arm_group_label>Healthy subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard carbohydrate meals</intervention_name>
    <description>Meal macronutritional energy composition:
Carbohydrate 55% Protein 15% Fat 30%</description>
    <arm_group_label>Type 2 diabetic subjects</arm_group_label>
    <arm_group_label>Prediabetic subjects</arm_group_label>
    <arm_group_label>Healthy subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men age 18-70 years

          -  Postmenopausal women age 55-70 years

          -  Non-smoker (abstinent at least 6 months)

          -  HbA1c &lt; 74 mmol/mol

          -  Fasting blood glucose &lt; 11 mmol/L (mean of 3 measurements)

          -  Negative (&lt;25 IU/L) plasma glutamate decarboxylase (GAD-65) antibodies (IgG)

          -  Hemoglobin &gt; 7.5 mmol/L (men); &gt; 6.8 mmol/L (women)

          -  Normal thrombocytes (140-400 x 109/L)

          -  eGFR &gt; 45 ml/min per 1.73 m2

          -  Alkaline phosphatase &lt; 140 IU/L

          -  Alanine aminotransferase &lt; 70 IU/L

          -  Normal International Normalized Ratio (0.9-1.2)

        Exclusion Criteria:

          -  Critical illness

          -  Anti-diabetic drugs other than metformin (maximum of 2000 mg / day)

          -  Steroid treatment e.g. prednisolone

          -  Reported or journalized severe food allergy or intolerance

          -  Reported or journalized gut disease e.g. Crohn's disease, Coeliac disease

          -  Reported or journalized alcohol dependence syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steen B Haugaard, MD, DMSc, associate prof.</last_name>
    <role>Study Director</role>
    <affiliation>Amager og Hvidovre Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thure Krarup, MD, DMSc</last_name>
    <role>Study Director</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amirsalar Samkani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrinological Dept. Bispebjerg University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Zealand</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2015</study_first_submitted>
  <study_first_submitted_qc>June 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2015</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Amirsalar Samkani</investigator_full_name>
    <investigator_title>MD, PhD-stud</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

